REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

General Discussion
5

Semax cognitive benefits - worth the hype?

Quinn Hoffman·22 days ago
I have been running this protocol for several weeks now and wanted to share my detailed experience with the community. Started with conservative dosing and gradually increased based on how I felt. Blood work has been monitored throughout.

Comments (8)

Lennox DaltonDEMO·2 months ago

The science behind this is fascinating. There was a recent paper published that supports what you are seeing clinically.

0
Jules DixonDEMO·about 2 months ago

The science behind this is fascinating. There was a recent paper published that supports what you are seeing clinically.

-1
August BrennanDEMO·about 1 month ago

The science behind this is fascinating. There was a recent paper published that supports what you are seeing clinically.

0
Hunter FrostDEMO·22 days ago

The science behind this is fascinating. There was a recent paper published that supports what you are seeing clinically.

2
Frankie HigginsDEMO·21 days ago

The blood work monitoring is great practice. Did you track BDNF levels? That is the primary mechanism by which Semax is thought to enhance cognition, and having baseline vs on-protocol BDNF data would be really informative.

0
Maple ArnoldDEMO·20 days ago

I ran NA-Semax Amidate which is the enhanced version. The cognitive effects were more pronounced than regular Semax for me but it also made me more wired. Had to stop using it after noon or it affected my sleep. Are you using regular Semax or one of the derivatives?

0
Sage BaileyDEMO·19 days ago

Worth the hype in my experience, but with caveats. The focus enhancement is real but it is not like Adderall - it is more of a clean, sustainable focus without the crash. I think people with ADHD or fatigue-driven cognitive issues benefit the most.

0
Beck ArcherDEMO·18 days ago

Conservative dosing and gradual increase is the right approach. I jumped in at 600mcg and felt overstimulated. Dropped to 200mcg and titrated up over 2 weeks which was much smoother. Your approach sounds similar and clearly working.

0

Sign in to comment.